PSC
NPTN

Piper Sandler & Co’s NEOPHOTONICS CORP NPTN Stock Holding History

Piper Sandler & Co’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$5K Buy
+300
New +$4.22K 0.01% 12

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Piper Sandler & Co's NPTN Position: Q3 2016 in Review

Piper Sandler & Co opened a new position in NEOPHOTONICS CORP (NPTN) in Q3 2016: 300 shares worth $5K. The stake represents 0.01% of the portfolio and ranks #12 among its holdings.

147 funds tracked by Wall St. Rank hold NPTN as of Q3 2016.

  • Piper Sandler & Co held 300 shares of NEOPHOTONICS CORP worth $5K as of Q3 2016.
  • NEOPHOTONICS CORP was a new Piper Sandler & Co position in Q3 2016.
  • NEOPHOTONICS CORP made up 0.01% of Piper Sandler & Co's portfolio in Q3 2016, its #12 holding.
  • 147 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2016.

Based on Piper Sandler & Co's 13F filing for Q3 2016, filed 14 Nov 2016.